Cargando…

Long-term survival and toxicity outcomes of intensity modulated radiation therapy for the treatment of esophageal cancer: A large single-institutional cohort study

PURPOSE: In patients with esophageal cancer (EC), intensity modulated radiation therapy (IMRT) improves dose sparing to the heart and lung, with some evidence showing clinical benefit. Herein, we report our cumulative clinical experience with the use of IMRT for EC. METHODS AND MATERIALS: This is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Anhui, Liao, Zhongxing, Allen, Pamela K., Ho, Linus, Murphy, Mariela Blum, Maru, Dipen M., Swisher, Stephen G., Hofstetter, Wayne L., Mehran, Reza J., Cox, James D., Komaki, Ritsuko, Lin, Steven H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Scientific Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605282/ https://www.ncbi.nlm.nih.gov/pubmed/29114598 http://dx.doi.org/10.1016/j.adro.2017.04.002

Ejemplares similares

Multi-institutional Evaluation of Curative Intent Chemoradiotherapy for Patients With Clinical T1N0 Esophageal Adenocarcinoma
por: Deng, Wei, et al.
Publicado: (2020)

Cancer associated macrophage-like cells and prognosis of esophageal cancer after chemoradiation therapy
por: Gironda, Daniel J., et al.
Publicado: (2020)

Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma
por: He, Li-Ru, et al.
Publicado: (2015)

Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer
por: Chang, Joe Y, et al.
Publicado: (2012)

Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma
por: Goense, Lucas, et al.
Publicado: (2018)

Taxane-based or platinum-based combination chemotherapy given concurrently with radiation followed by surgery resulting in high cure rates in esophageal cancer patients
por: Lopez, Anthony, et al.
Publicado: (2020)

Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma
por: Tong, Zhimin, et al.
Publicado: (2017)

Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial
por: Shimodaira, Yusuke, et al.
Publicado: (2018)

Targeting CDK9 and MCL-1 by a new CDK9/p-TEFb inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma
por: Tong, Zhimin, et al.
Publicado: (2019)

Endoscopic Intrapyloric Botulinum Toxin Injection with Pyloric Balloon Dilation for Symptoms of Delayed Gastric Emptying after Distal Esophagectomy for Esophageal Cancer: A 10-Year Experience
por: Bhutani, Manoop S., et al.
Publicado: (2022)

A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries
por: Veeranki, Omkara Lakshmi, et al.
Publicado: (2019)

Targeting cyclin-dependent kinase 9 by a novel inhibitor enhances radiosensitization and identifies Axl as a novel downstream target in esophageal adenocarcinoma
por: Veeranki, Omkara Lakshmi, et al.
Publicado: (2019)

Utility of endoscopic ultrasound-guided fine-needle aspiration of regional lymph nodes that are proximal to and far from the primary distal esophageal carcinoma
por: Shimodaira, Yusuke, et al.
Publicado: (2017)

Outcomes and Tolerability of Definitive and Preoperative Chemoradiation in Elderly Patients With Esophageal Cancer: A Retrospective Institutional Review
por: Rahimy, Elham, et al.
Publicado: (2020)

Dosimetric and clinical outcomes after volumetric modulated arc therapy for carcinoma of the thoracic esophagus
por: Xu, Cai, et al.
Publicado: (2017)

Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging without increasing toxicity: A matched-pair analysis
por: Gunther, Jillian R., et al.
Publicado: (2017)

A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma
por: Skinner, Heath D, et al.
Publicado: (2014)

Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma: a single institutional experience
por: Prayongrat, Anussara, et al.
Publicado: (2017)

Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer
por: Amini, Arya, et al.
Publicado: (2012)

Barriers to surveillance imaging adherence in early-staged lung cancer
por: Bostock, Ian C., et al.
Publicado: (2021)

Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series
por: Juarez, Jesus E., et al.
Publicado: (2021)

Phase I Study of Celecoxib with Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer
por: Komaki, Ritsuko, et al.
Publicado: (2011)

Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial
por: Parzen, Jacob S., et al.
Publicado: (2021)

Outcomes of re-irradiation for brain recurrence after prophylactic or therapeutic whole-brain irradiation for small cell lung Cancer: a retrospective analysis
por: Suzuki, Ryoko, et al.
Publicado: (2018)

The Potential Role of Respiratory Motion Management and Image Guidance in the Reduction of Severe Toxicities Following Stereotactic Ablative Radiation Therapy for Patients with Centrally Located Early Stage Non-Small Cell Lung Cancer or Lung Metastases
por: Chi, Alexander, et al.
Publicado: (2014)

Esophageal motion characteristics in thoracic esophageal cancer: Impact of clinical stage T4 versus stages T1-T3
por: Kobayashi, Yuta, et al.
Publicado: (2016)

Acute Toxicities and Short-Term Patient Outcomes After Intensity-Modulated Proton Beam Radiation Therapy or Intensity-Modulated Photon Radiation Therapy for Esophageal Carcinoma: A Mayo Clinic Experience
por: Bhangoo, Ronik S., et al.
Publicado: (2020)

Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529
por: Mitra, Devarati, et al.
Publicado: (2017)

Predictors of Financial Toxicity in Patients Receiving Concurrent Radiation Therapy and Chemotherapy
por: Jiang, Julie M., et al.
Publicado: (2022)

Prognostic Biomarkers for Esophageal Adenocarcinoma Identified by Analysis of Tumor Transcriptome
por: Kim, Soo Mi, et al.
Publicado: (2010)

Minimally Invasive Surgical Treatment of Esophageal Achalasia
por: Ramacciato, Giovanni, et al.
Publicado: (2003)

Esophageal Lipoma and Liposarcoma: A Systematic Review
por: Ferrari, Davide, et al.
Publicado: (2020)

Adoption of Robotic Sacrocolpopexy at an Academic Institution
por: Bradley, Megan S., et al.
Publicado: (2014)

Genetic Variants in Inflammation-Related Genes Are Associated with Radiation-Induced Toxicity Following Treatment for Non-Small Cell Lung Cancer
por: Hildebrandt, Michelle A. T., et al.
Publicado: (2010)

What Would Be the Most Appropriate α/β Ratio in the Setting of Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer
por: Chi, Alexander, et al.
Publicado: (2013)

Safe Esophageal Bougie Placement for Laparoscopic Hiatal Hernia Repair
por: Edelman, David S., et al.
Publicado: (1998)

Independent test of a model to predict severe acute esophagitis
por: Huang, Ellen X., et al.
Publicado: (2016)

CO(2) exacerbates oxygen toxicity
por: Ezraty, Benjamin, et al.
Publicado: (2011)

Overview of available toxicity data for calystegines
por: Binaglia, Marco, et al.
Publicado: (2019)

Early Experience With Laparoscopic Pyloromyotomy in a Teaching Institution
por: Hendrickson, Richard J., et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_c7bv9b40j115idouc167o99s3e